Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-Capecitabine
March 17, 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
The 300 mg dose group will provide more information on the drug exposure vs adverse event relationship which is critical to FDA approval given the FDA’s Project Optimus Oncology initiative.Patients...
MetAlert Announces the Launch of its Next Generation 4G GPS SmartSole in the U.K.
March 08, 2023 08:19 ET
|
MetAlert Inc.
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring,...
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...
QSAM Biosciences Completes Enrollment of Initial Cohort in its Phase 1 Study of CycloSam® Targeting Metastatic Bone Cancer
February 28, 2023 08:00 ET
|
QSAM Biosciences Inc.
Austin, TX, Feb. 28, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
Processa Pharmaceuticals, Inc. Announces Closing of $6.25 Million Registered Direct Offering, Which Included Retail Investors and Insiders, Priced at the Market Under Nasdaq Rules
February 15, 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a diversified clinical-stage company developing next generation...
Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
February 10, 2023 08:00 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a diversified clinical-stage company developing next generation...
Metalert Announces the Launch of its Next Generation 4G GPS SmartSole in Sweden
January 25, 2023 08:21 ET
|
MetAlert Inc.
LOS ANGELES, Jan. 25, 2023 (GLOBE NEWSWIRE) -- MetAlert, Inc. (OTC: MLRT), announces the launch of its new 4G GPS SmartSole in Sweden through its distribution partner Posifon AB. The upgraded GPS...
Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial
November 01, 2022 08:30 ET
|
Processa Pharmaceuticals, Inc.
Next Generation Capecitabine (NGC) Dosage Regimens Have Been Identified In The Ongoing Phase 1B Trial With Potentially Better Safety And Efficacy Profiles Than Existing Chemotherapy These NGC...
Digital Ally Announces Next Generation Fleet Video Solution
October 31, 2022 09:00 ET
|
Digital Ally, Inc.
EVO Fleet Vehicle Camera utilizes the latest innovations in telematics technology Lenexa, KS, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), today announced...
CareCloud Wellness Brings Providers Next Generation Chronic Care Management Services
August 29, 2022 09:15 ET
|
CareCloud, Inc
CareCloud initially launches turnkey solution with providers in 10 states, eight healthcare specialties SOMERSET, N.J., Aug. 29, 2022 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: MTBC,...